Terumo Heart, Inc. Reaches Clinical Milestone As The 100th Patient Worldwide Receives The DuraHeart(TM) Left Ventricular Assist System

Terumo Heart Inc., a wholly owned subsidiary of Terumo Corporation, announced reaching a critical milestone in the worldwide expansion of its DuraHeart(TM) Left-Ventricular Assist System (LVAS) as the 100th patient was treated by Latif Arusoglu, MD and Michiel Morshuis, MD, cardiothoracic surgeons at the Clinic for Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, University Hospital of the Ruhr-University of Bochum in Bad Oeynhausen, Germany.